Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1043 | 997 | 1231 | 1011 | 1608 | 2775 |
Fund Return | 4.3% | -0.28% | 23.15% | 0.35% | 9.97% | 10.75% |
Place in category | 2306 | 2275 | 830 | 1332 | 842 | 71 |
% in Category | 78 | 76 | 29 | 56 | 49 | 8 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LO All Roads, Syst Hdg, USD MA | 2.15B | 5.19 | 3.26 | 4.52 | ||
LO All Roads, Syst Hdg, USD PA | 2.15B | 4.99 | 2.79 | 4.05 | ||
LGeneration Global USD M A | 1.95B | 4.21 | 0.16 | 10.56 | ||
LGeneration Global USD M D | 1.95B | 4.21 | 0.15 | 10.55 | ||
LGeneration Global USD P A | 1.95B | 4.03 | -0.22 | 10.28 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Capital Group New Perspective Fuzdu | 14.38B | 8.70 | 2.61 | 10.05 | ||
Cap Group New Perspective lux N USD | 14.38B | 8.09 | 1.17 | - | ||
Capital Group New Perspective Fuzgu | 14.38B | 8.68 | 2.61 | 10.06 | ||
Capital Group New Perspective Fubu | 14.38B | 8.35 | 1.84 | 9.18 | ||
Capital Group New Perspective Fubdu | 14.38B | 8.37 | 1.84 | 9.18 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amazon.com | US0231351067 | 7.58 | 186.34 | +0.41% | |
Microsoft | US5949181045 | 7.55 | 450.95 | +0.73% | |
Applied Materials | US0382221051 | 4.89 | 234.32 | +1.95% | |
Thermo Fisher Scientific | US8835561023 | 3.37 | 556.52 | -1.67% | |
Nutanix | US67059N1081 | 3.33 | 53.42 | +1.23% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review